Evaluation of 'Melody' Paracentesis Device for Ascites Therapy
EMPATHY
1 other identifier
interventional
101
1 country
1
Brief Summary
Ascites is the accumulation of fluid inside the abdomen. This can happen when the liver fails due to a substantial amount of scarring (cirrhosis). Patients (pts) must have this fluid drained and as cirrhosis progresses, patients will require drainage of ascites repeatedly on a regular basis, leading to frequent hospitals visits and increased complications. The current drainage device is slow and doesn't always drain completely so pts have to return repeatedly to keep symptoms under control. A new device (called Melody) has been developed and specifically designed for the purpose of draining ascites fluid, which the Investigators expect to drain faster and completely. This study will compare the volume of ascites drained using the new 'Melody' catheter device with that used in standard NHS practice. If the melody catheter device is confirmed as superior to the current device this would improve patient experience (less frequent visits to hospital and increased length of time between visits). With fewer procedures performed per patient, the pressure on the NHS would be greatly reduced in terms of time and costs.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2016
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 4, 2016
CompletedFirst Submitted
Initial submission to the registry
December 1, 2016
CompletedFirst Posted
Study publicly available on registry
June 19, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 10, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
January 10, 2019
CompletedNovember 19, 2020
November 1, 2020
3 years
December 1, 2016
November 18, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Amount of ascites fluid drained (litres)
Amount of ascites fluid drained in one session (litres)
Up to 6 hours
Secondary Outcomes (1)
Adverse Events
Up to 7 days
Study Arms (3)
Standard Device
ACTIVE COMPARATORStandard device
Melody Device
EXPERIMENTALMelody device without Pump
Melody Device with pump
EXPERIMENTALMelody Catheter device with Andromeda Pump
Interventions
paracentesis using Melody Device with Pump
Eligibility Criteria
You may qualify if:
- Ascites due to cirrhosis of the liver.
- Aged 18-80 years.
- Ability to give written consent.
You may not qualify if:
- Known untreated spontaneous bacterial peritonitis.
- Disseminated intravascular coagulation at the time of consenting.
- Pregnancy.
- Patients who have had more than six ascitic drainage procedures.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Nottinghamlead
- Mediplus Ltd UKcollaborator
- Enteric healthcare technology Co-operativecollaborator
Study Sites (1)
Queen Day Case Unit Nottingham University Hospitals NHS Trust
Nottingham, NG7 2UH, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Guruprasad Aithal
NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust & University of Nottingham
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 1, 2016
First Posted
June 19, 2017
Study Start
January 4, 2016
Primary Completion
January 10, 2019
Study Completion
January 10, 2019
Last Updated
November 19, 2020
Record last verified: 2020-11
Data Sharing
- IPD Sharing
- Will not share